Clinical Trials Directory

Trials / Conditions / Advanced Endometrial Cancer

Advanced Endometrial Cancer

10 registered clinical trials studyying Advanced Endometrial Cancer — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEfficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Canc
NCT05077215
Evergreen Therapeutics, Inc.Phase 3
Not Yet RecruitingSafety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem
NCT05106127
Evergreen Therapeutics, Inc.Phase 2
RecruitingStudy of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
NCT06584032
HutchmedPhase 3
RecruitingA Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha
NCT06547840
Epsilogen LtdPhase 1
RecruitingA Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
NCT06758557
Huabo Biopharm Co., Ltd.Phase 1 / Phase 2
WithdrawnGEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer
NCT06046274
GenmabPhase 2
TerminatedEfficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Adv
NCT05481645
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2
RecruitingStudy of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
NCT05112991
3D Medicines (Sichuan) Co., Ltd.Phase 2
CompletedA Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometri
NCT04574284
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2
CompletedBKM120 as Second-line Therapy for Advanced Endometrial Cancer
NCT01289041
Novartis PharmaceuticalsPhase 2